• Home
  • About
  • Repositories
  • Search
  • Web API
  • Feedback
<< Go Back

Metadata

Name
huCART19-IL18 in NHL/CLL Patients
Repository
ClinicalTrials.gov
Identifier
clinicaltrials:NCT04684563
Description
The purpose of this study is to find the maximum dose of huCART19-IL18 cells that is safe for
use in humans with Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL).
Data or Study Types
clinical trial
Keywords
CLL, NHL, CAR-T cells
Source Organization
Unknown
Access Conditions
available
Year
2020
Access Hyperlink
https://clinicaltrials.gov/ct2/show/NCT04684563

Distributions

  • Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT04684563
This project was funded in part by grant U24AI117966 from the NIH National Institute of Allergy and Infectious Diseases as part of the Big Data to Knowledge program. We thank all members of the bioCADDIE community for their valuable input on the overall project.